174 related articles for article (PubMed ID: 14689192)
1. [Hormone therapy in menopause. A current update].
Seifert-Klauss V; Schumm-Draeger PM
Internist (Berl); 2003 Dec; 44(12):1500-7. PubMed ID: 14689192
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
3. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
[TBL] [Abstract][Full Text] [Related]
4. [After discontinuation of the Women's Health Initiative Study of hormone substitution. Should hormone replacement be stopped? (interview by Dr. Brigitte Moreano)].
Seifert-Klauss V
MMW Fortschr Med; 2002 Jul; 144(29-30):16. PubMed ID: 12219606
[No Abstract] [Full Text] [Related]
5. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
Ness J; Aronow WS; Newkirk E; McDanel D
J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk in the WHI study: the problem of obesity.
Kuhl H
Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
[TBL] [Abstract][Full Text] [Related]
7. [Menopausal hormone treatment in 2011].
Rozenberg S; Vandromme J; Antoine C
Rev Med Brux; 2011 Sep; 32(4):239-42. PubMed ID: 22034751
[TBL] [Abstract][Full Text] [Related]
8. Climacteric: concept, consequence and care.
Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
[TBL] [Abstract][Full Text] [Related]
9. KEEPS: The Kronos Early Estrogen Prevention Study.
Harman SM; Brinton EA; Cedars M; Lobo R; Manson JE; Merriam GR; Miller VM; Naftolin F; Santoro N
Climacteric; 2005 Mar; 8(1):3-12. PubMed ID: 15804727
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone therapy: cardiovascular risks.
Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
[TBL] [Abstract][Full Text] [Related]
11. [Menopause in 2004: "hormone replacement therapy" is not what it used to be anymore].
Azoulay C
Rev Med Interne; 2004 Nov; 25(11):806-15. PubMed ID: 15501350
[TBL] [Abstract][Full Text] [Related]
12. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
13. The case for hormone replacement: new studies that should inform the debate.
Thacker HL
Cleve Clin J Med; 2002 Sep; 69(9):670, 672-3, 677-8. PubMed ID: 12222970
[TBL] [Abstract][Full Text] [Related]
14. Perimenopausal and postmenopausal hormone replacement therapy. Part 1. An update of the literature on benefits and risks.
Lichtman R
J Nurse Midwifery; 1996; 41(1):3-28. PubMed ID: 8820754
[TBL] [Abstract][Full Text] [Related]
15. ["Menopause medicine" a growing discipline. Many questions on hormones and women's health are still unanswered].
von Schoultz B
Lakartidningen; 2001 Jan; 98(5):412-6. PubMed ID: 11229081
[No Abstract] [Full Text] [Related]
16. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
17. [Hormone replacement therapy and the risk of developing breast cancer].
Merz WE
MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
[TBL] [Abstract][Full Text] [Related]
18. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
Parish SJ; Gillespie JA
Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
[TBL] [Abstract][Full Text] [Related]
19. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy.
Sammartino A; Cirillo D; Mandato VD; Di Carlo C; Nappi C
J Endocrinol Invest; 2005; 28(10 Suppl):80-4. PubMed ID: 16550729
[TBL] [Abstract][Full Text] [Related]
20. Side-effects of hormone replacement therapy and influence on pattern of use among women aged 45-64 years. The Norwegian Women and Cancer (NOWAC) study 1997.
Bakken K; Eggen AE; Lund E
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):850-6. PubMed ID: 15315597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
